Clin2
NCT06866496Possibly a fitRecruiting

Better remission in alcohol-related liver cirrhosis

Cirrhosis of the LiverAlcoholic Cirrhosis

Part of Digestive system clinical trials.

This trial tests if an optimized treatment plan can improve remission in people with liver cirrhosis caused by alcohol. It aims to help patients achieve better health outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
350 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have liver cirrhosis that your doctor believes is related to alcohol use.
  • Your diagnosis is supported by blood tests and imaging (like ultrasound).
  • You are able to give written consent to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04689152Recruiting· Phase 3
Cell treatment via liver artery catheter for alcoholic cirrhosis

This Phase 3 trial tests whether a cell medicine called Cellgram-LC, delivered through a catheter into the liver artery, is safer and works better for people with alcoholic cirrhosis. It may help improve outcomes in people with more advanced liver scarring.

Bucheon-si
NCT06740318Recruiting
Reversing liver damage in alcohol-related hepatitis

This trial studies whether people with alcohol-related hepatitis can see their liver function improve. It looks at patients whose diagnosis is supported by blood tests and imaging, and excludes those with liver cancer.

Hvidovre
NCT06493773Recruiting
Alcohol help for new liver disease diagnosis

This trial tests a program to help people recently diagnosed with alcohol-related liver disease cut back on drinking. If you qualify, you may get support to improve your liver health.

Køge, Køge
NCT04149223Recruiting
Hospital program to improve care for adults with cirrhosis

This trial tests a practical hospital-based program to improve how care is delivered to adults with cirrhosis. If you’re eligible, you may receive care that follows the trial’s improved approach and helps the team learn what works best.

Edmonton, Alberta
NCT06613698Recruiting· Phase 2
Testing an investigational drug for alcohol-related liver disease

This trial tests whether a new drug, GSK4532990, is safe and effective compared to a placebo in adults aged 18 to 70 with liver disease caused by alcohol use. The study aims to see if the drug can help treat advanced chronic liver disease.

Chandler, Arizona
NCT07060638Recruiting· Phase 2
Combination therapy for severe alcoholic hepatitis

This trial tests a combination of treatments for people with severe alcohol-related liver disease (alcoholic hepatitis) that has not responded to standard care. The goal is to improve liver function and help you stop drinking.

Indianapolis, Indiana

Hear when a new Alcoholic Cirrhosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.